NRXP 8-K: SEC filing
Filed with the SEC on · accession 0001437749-26-030228
NRXP filed a 8-K (current report) with the SEC on Sep 14, 2026. NRx Pharmaceuticals furnished an investor presentation (Exhibit 99.1) under Regulation FD for use in meetings with investors and analysts. The stock moved +2.6% by the first close after the filing.
Summary of the filing
NRx Pharmaceuticals furnished an investor presentation (Exhibit 99.1) under Regulation FD for use in meetings with investors and analysts. The filing contains no material corporate action or financial results.
Key details
How NRXP stock reacted
Close before
$3.40
Sep 11, 2026
First close after
+2.65%
$3.49
5 trading days
-2.35%
$3.32
Since filing
-30.00%
$2.38
✦ Ask GOAX AI about this filing — what it means for NRXP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NRXP?
Click hereFrequently asked questions
What did NRXP file with the SEC on Sep 14, 2026?
NRXP filed a 8-K (SEC filing). NRx Pharmaceuticals furnished an investor presentation (Exhibit 99.1) under Regulation FD for use in meetings with investors and analysts. The filing contains no material corporate action or financial results.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did NRXP stock react to this filing?
NRXP closed at $3.40 before the filing and $3.49 on Sep 14, 2026 (+2.65%). Five trading days later: $3.32 (-2.35%).
Other NRXP SEC filings
- DEF 14A · Board changeNov 5, 2026
- 8-K · Fda approvalNov 2, 2026
- 8-K · SEC filingOct 16, 2026
- 8-K · Contract winOct 5, 2026
- 8-K · Fda approvalSep 16, 2026
- 8-K · SEC filingAug 17, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · Fda approvalAug 7, 2026
- 8-K · Contract winJul 22, 2026
- 8-K · Secondary offeringJun 4, 2026
Get alerts when NRXP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days